subject area of
- A review of the two major regulatory pathways for non-proprietary low-molecular-weight heparins Journal Articles
- Assessing 15 Proposals for Promoting Innovation and Access to Medicines Globally Journal Articles
- Australian medical patents granted in the United States in 1984‐1999 Journal Articles
- Bill C-91: the debate continues. Journal Articles
- Canada’s Amendment to Patented Drug Price Regulation Journal Articles
- Canada’s laws on pharmaceutical intellectual property: the case for fundamental reform: Figure 1: Journal Articles
- Could patents interfere with the development of a cardiovascular polypill? Journal Articles
- Divergence and Convergence of Royalty Determinations between Compulsory Licensing under the TRIPS Agreement and Ongoing Royalties as an Equitable Remedy Journal Articles
- How should we support pharmaceutical innovation? Journal Articles
- Nematicidal Substances from Fungi Journal Articles
- New approaches to rewarding pharmaceutical innovation Journal Articles
- Predicting commercial success for Australian medical inventions patented in the United States: a cross sectional survey of Australian inventors Journal Articles
- Primary-Consistent Soft-Decision Color Demosaicking for Digital Cameras (Patent Pending) Journal Articles
- Re: Ostry A. The new international trade regime: problems for publicly funded healthcare in Canada? (Editorial) CJPH 2001; 92(1):5-6. Journal Articles
- Taking tissue seriously means taking communities seriously Journal Articles
- The impact of changing the reference countries on the list prices for patented medicines in Canada: A policy analysis Journal Articles
- The impact of proposed price regulations on new patented medicine launches in Canada: a retrospective cohort study Journal Articles
- Value of Information and Pricing New Healthcare Interventions Journal Articles